Institutional investors purchased a net $1.1 million shares of VSTM during the quarter ended March 2014. This may signal that the smart money is gaining interest in this company as the 52.99% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STONERIDGE INVESTMENT PARTNERS L... Sold 1.2 Thousand shares of Verastem Inc
EMERALD ADVISERS, INC. Sold 57.2 Thousand shares of Verastem Inc
OXFORD ASSET MANAGEMENT LLP Sold 63.1 Thousand shares of Verastem Inc